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EuroQol values for economic modeling quality of life
after infrainguinal bypass grafting surgery: a
rectification
To the Editors:
In the May edition of the Journal of Vascular Surgery,
the outcomes of our investigation into the quality of life
after infrainguinal bypass grafting surgery were published.1
Unfortunately, the graph that accompanied the article only
contained the EuroQol values for the female patients.
Fortunately, the error did not jeopardize the main interpre-
tation of the results because we found no evidence of inter-
action between gender and group variables. We were inter-
ested in differences between groups, and these differences
were not influenced by the (constant) differences between
sex. Because all the results were interpreted as relative values
between patient groups, the constant differences between
men and women did not play a role in the formulation of
the conclusion. Nevertheless, in the judging of the absolute
values of quality of life, the graph suggested a lower average
quality of life than was actually measured because women,
in general, valued their quality of life lower than men. In
other words, the values that were presented in the graph
underestimated the average quality of life. This error ranged
from 4 to 10 points on a scale from 0 to 100.
Although the low values in the graph did not affect
the interpretation of the results of this particular investi-
gation, the values may lead to erroneous conclusions when
they are judged as absolute values. In particular, this situ-
ation may arise when these values are used in cost-effec-
tiveness analyses and in the economic modeling of out-
comes. In a cost-effectiveness analysis, the outcomes of an
intervention are compared with other health care inter-
ventions. Obviously, if the low values that were presented
in the original graph are used, then the conclusions of
such comparisons may be erroneous. This observation
applies particularly to the EuroQol data because these val-
ues are often used in economic evaluation and modeling.
For this reason, we present the EuroQol values for both
men and women in Table I.
Table I presents two different EuroQol scores on the
basis of a multilevel analysis.1 The EQVAS is the value that
patients attribute to their own current health state with the
placement of a mark on a visual analogue scale, labeled
from 0 (worst imaginable health state) to 100 (best imag-
inable health state). These values represent the patient’s
perspective. The EQ-5Dindex is a weighted aggregated
score for the five EuroQol dimensions of quality of life.
This index score is based on the values of the general pub-
lic and therefore represents the societal perspective, which
is the preferred perspective in the economic evaluation of
health care. In this case, the weighing was on the basis of
responses from a sample of 3000 households in the United
Table I. Quality of life after infrainguinal bypass grafting on the basis of the EuroQol questionnaire
Women Men
Mean score 95% CI Mean score 95% CI
EQ-5Dindex
Patent graft 0.63 0.59 - 0.66 0.71 0.67 - 0.74
Asymptomatic occlusion 0.59 0.50 - 0.68 0.67 0.58 - 0.76
Symptomatic occlusion 0.52 0.45 - 0.58 0.60 0.53 - 0.66
Revascularization 0.53 0.49 - 0.57 0.61 0.57 - 0.65
Primary amputation 0.43 0.33 - 0.53 0.51 0.41 - 0.61
Secondary amputation 0.33 0.24 - 0.43 0.41 0.32 - 0.51
Cerebrovascular accident 0.40 0.29 - 0.51 0.48 0.37 - 0.59
Myocardial infarction 0.51 0.37 - 0.65 0.59 0.45 - 0.73
EQVAS
Patent graft 64.49 62.08 - 66.90 70.00 67.59 - 72.41
Asymptomatic occlusion 64.90 59.12 - 70.68 70.41 64.63 - 76.19
Symptomatic occlusion 57.62 53.35 - 61.89 63.13 58.86 - 67.40
Revascularization 61.06 58.29 - 63.83 66.57 63.80 - 69.34
Primary amputation 59.72 53.37 - 66.07 65.23 58.88 - 71.58
Secondary amputation 55.09 48.99 - 61.19 60.60 54.50 - 66.70
Cerebrovascular accident 49.44 41.83 - 57.05 54.95 47.34 - 62.56
Myocardial infarction 52.46 43.00 - 61.92 57.97 48.51 - 67.43
CI, Confidence interval.
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Kingdom.2 This EQ-5Dindex has a range from –1.00 to
1.00, in which the value 1.00 represents health without
morbidity, 0.00 represents morbidity with the same value
as death, and –1.00 is the lowest value for health states with
values lower than death. These values are based on time
trade-off, which makes them especially suitable for the
analysis of quality-adjusted life years. When the EuroQol
values are used in a model, the values should be weighed
for the proportion of male and female patients.
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Regarding “A prospective study to assess changes in
proximal aortic neck dimensions after endovascular
repair of abdominal aortic aneurysms”
To the Editors:
We read with interest the article by Dr Stuart R. Walker
and colleagues (J Vasc Surg 1999;29:625-30) regarding the
dimensions of the proximal aortic neck after endovascular
repair. The growth of the proximal endograft fixation area is
one of the most important potential risks of long-term fail-
ure of this new form of treatment. We have performed a sim-
ilar study in 33 of our patients, and we found significant
increases after 6 and 12 months of follow-up examination.
This has been in agreement with similar reports.1-3 Contrary
to these earlier studies, Walker and colleagues found no sig-
nificant changes of the proximal neck.
Although our own study may appear to have limited
numbers at first glance, we only included the patients with
at least 6 months of follow-up examination because we
were interested in the long-term changes. In Walker’s
study, only 30 of 112 patients had a follow-up period of at
least 6 months. The added 82 patients with less than 6
months of follow-up examination are of no value to their
analysis, and the limited number of patients with a longer
follow-up period is probably the most important reason
why their study results are negative. Apart from this type
II statistical error, we believe that there are several other
reasons why the study results are false negative.
The measurements were done at levels that were rela-
tive to the renal artery and not relative to the stented area.
As a consequence, the dataset of each level contains the
measurements of both stented and nonstented necks.
Because the presence of an attachment system and its radi-
al force is likely to have an impact on the local neck dimen-
sions, this method leads to an underestimation of the local
effect of the radial force. The authors should at least have
included one set of measurements at the level of the
attachment frame in all the patients.
Despite the relatively small number of patients avail-
able with at least 2 years of follow-up examination, we
were surprised to find an almost significant (P = .06)
increase of 3.4 mm at level “D2b”, 5 mm below the low-
est renal artery. The designation of such a change as non-
significant is, in our view, a false interpretation of the sta-
tistical test.
Although their method is not described exactly, the
measurements appeared to have been taken off of three-
dimensional reconstructions. We agree that the measure-
ments must be taken perpendicular to the vessel axis for
which three-dimensional reformats are necessary, but we
are unaware of the added value of three-dimensional mod-
els and we expect the measurements from cut films to be
more accurate.
It is unclear how many patients were excluded from the
analysis as the result of untimely death or conversion to con-
ventional repair. This patient group might harbor cases of
proximal endograft migration caused by neck dilation and
therefore may bias the results to a negative outcome.
Finally, we would like to make the point that neck
changes may vary with the type of attachment system
used. Stent fixation mechanisms with a high radial force,
but also balloon expandable stents, are likely to attain their
nominal size quickly after deployment. Because endograft
attachment frames are generally oversized relative to the
proximal aortic neck diameter, an (intended) elastic
stretch of the aorta at that level will occur. Over time, this
elastic quality of the stented aorta may wear out and, with
this, the frictional forces that keep the stent in place will
decline. Although this scenario is theoretical, it illustrates
that size measurements at the level of a stent that already
reached its maximum size will not show the loss of elastic
properties. Consequently, the stability of the size of such
an aortic neck may falsely suggest that the endograft fixa-
tion may still be adequate.
